LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 97.76

Change

-6.59 (-6.32)%

Market Cap

USD 0.28B

Volume

2.17M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-15 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.66B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

N/A

USD 4.15B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 3.97B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 2.73B
FAS Direxion Daily Financial Bull .. 1.04 %

N/A

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

N/A

USD 2.23B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 0.96B

ETFs Containing LABU

ULTY Tidal Trust II 5.23 % 0.00 %

N/A

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.85% 10% F 7% C-
Dividend Return 0.13% 23% F 5% F
Total Return -19.72% 9% A- 7% C-
Trailing 12 Months  
Capital Gain -17.01% 18% F 16% F
Dividend Return 0.50% 15% F 4% F
Total Return -16.52% 15% F 14% F
Trailing 5 Years  
Capital Gain -89.90% 4% F 2% F
Dividend Return 0.17% 3% F 1% F
Total Return -89.73% 3% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain 9.41% 40% F 70% C-
Dividend Return 9.46% 39% F 64% D
Total Return 0.05% 5% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 352.56% 12% F 2% F
Risk Adjusted Return 2.68% 31% F 29% F
Market Capitalization 0.28B 87% B+ 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.